Comparison of efficacy, safety, and cost-effectiveness of montelukast-levocetirizine and montelukast-fexofenadine in patients of allergic rhinitis: A randomized, double-blind clinical trial

OBJECTIVES: Allergic rhinitis (AR) is a global health problem. Almost 10%–25% of population worldwide is affected by AR. Oral/intranasal H1-antihistamine, decongestants, leukotriene receptor antagonists, and intranasal corticosteroids are the pillars in the management of AR. The combination therapy...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Indian J Pharmacol
Päätekijät: Mahatme, Mohini Sachin, Dakhale, Ganesh Natthuji, Tadke, Kanchan, Hiware, Sachin Keshaorao, Dudhgaonkar, S. D., Wankhede, Sumit
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Medknow Publications & Media Pvt Ltd 2016
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5155464/
https://ncbi.nlm.nih.gov/pubmed/28066101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0253-7613.194854
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia